NCT02302430View on ClinicalTrials.gov

Intranasal Oxytocin and Enhancement of Team Cohesion

PHASE1CompletedINTERVENTIONAL
Enrollment

486

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2019

Conditions
Unit Cohesion
Interventions
DRUG

Oxytocin

20 International Units Intranasal Oxytocin

OTHER

Placebo comparator

Saline nasal spray

Trial Locations (1)

94121

San Francisco VA Medical Center, San Francisco

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

San Francisco Veterans Affairs Medical Center

FED

lead

University of California, San Francisco

OTHER

NCT02302430 - Intranasal Oxytocin and Enhancement of Team Cohesion | Biotech Hunter | Biotech Hunter